We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications—a review.
- Authors
Macciò, Antonio; Madeddu, Clelia
- Abstract
An increasing number of studies emphasize the role of inflammation and metabolic changes in the induction of cancer-related symptoms, which can affect cancer evolution and prognosis. These changes result from the interactions between the tumor and the host. To date, however, markers of this peculiar condition, which can help clinicians to manage patients better, have still not been identified with certainty. Epithelial ovarian cancer (EOC) appears to be particularly appropriate to study these interactions because of its biological characteristics, its peculiar evolution, and the relevant scientific evidence available. Immunosuppression, anemia, depression, and weight loss affect the evolution of EOC and appear to be directly related to the immune-metabolic changes. In light of the aforementioned evidence, our review will focus on interleukin-6 (IL-6) and its role as potential marker of the patients’ immune-metabolic status, to better monitor disease outcome and identify the most appropriate therapeutic strategy in EOC. Furthermore, leptin will be discussed as a sensor of the changes of energy metabolism induced by IL-6.
- Subjects
INTERLEUKIN-6; OVARIAN cancer; ENERGY metabolism; WEIGHT loss; IMMUNOSUPPRESSION; ANEMIA; PROGNOSIS
- Publication
Journal of Molecular Medicine, 2013, Vol 91, Issue 12, p1355
- ISSN
0946-2716
- Publication type
Article
- DOI
10.1007/s00109-013-1080-7